FLSM
Frazier Life Sciences Management Portfolio holdings
AUM
$2.5B
This Quarter Return
+42.11%
1 Year Return
+52.94%
3 Year Return
+530.54%
5 Year Return
–
10 Year Return
–
AUM
$2.37B
AUM Growth
+$2.37B
(+27%)
Cap. Flow
+$123M
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
58.56%
Holding
56
New
7
Increased
13
Reduced
6
Closed
6
Top Buys
| 1 |
CG Oncology
CGON
|
$33.8M |
| 2 |
Oric Pharmaceuticals
ORIC
|
$27.5M |
| 3 |
PepGen
PEPG
|
$22.1M |
| 4 |
BridgeBio Pharma
BBIO
|
$21.3M |
| 5 |
Soleno Therapeutics
SLNO
|
$17.6M |
Top Sells
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$16.1M |
| 2 |
Dyne Therapeutics
DYN
|
$15.8M |
| 3 |
Crinetics Pharmaceuticals
CRNX
|
$14.1M |
| 4 |
89bio
ETNB
|
$11.6M |
| 5 |
Apogee Therapeutics
APGE
|
$11.2M |
Sector Composition
| 1 | Healthcare | 99.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Apogee Therapeutics
APGE
$2.17B
| – | – | -400,000 | Closed | -$11.2M |
|
|
52
Crinetics Pharmaceuticals
CRNX
$2.92B
| – | – | -397,483 | Closed | -$14.1M |
|
|
53
Dyne Therapeutics
DYN
$1.92B
| – | – | -1,184,840 | Closed | -$15.8M |
|
|
54
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -69,406 | Closed | -$16.1M |
|
|
THRX
55
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| – | – | -2,118,051 | Closed | -$8.58M |
|
|
MRTX
56
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – | -80,000 | Closed | -$4.7M |
|